Answer
Women of reproductive potential should use effective contraception during enfortumab vedotin treatment and for at least 6 months after stopping treatment.
Sources for this answer
- Padcev 20 mg and 30 mg powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked